Gregory O. Clark

1.1k total citations
7 papers, 855 citations indexed

About

Gregory O. Clark is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Gregory O. Clark has authored 7 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Gregory O. Clark's work include Pancreatic function and diabetes (4 papers), Diabetes Management and Research (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Gregory O. Clark is often cited by papers focused on Pancreatic function and diabetes (4 papers), Diabetes Management and Research (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Gregory O. Clark collaborates with scholars based in United States. Gregory O. Clark's co-authors include Roger H. Unger, Philipp E. Scherer, Lelio Orci, May-Yun Wang, Robert D. Stevens, Brett R. Wenner, James R. Bain, Maureen Charron, Young Lee and Christopher B. Newgard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

Gregory O. Clark

7 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory O. Clark United States 7 344 245 239 229 209 7 855
Frederick T. Fiedorek United States 8 297 0.9× 190 0.8× 181 0.8× 214 0.9× 248 1.2× 10 712
Agathoklis Psyrogiannis Greece 14 351 1.0× 116 0.5× 267 1.1× 488 2.1× 130 0.6× 18 1.2k
Wataru Kameda Japan 19 309 0.9× 177 0.7× 400 1.7× 300 1.3× 124 0.6× 49 1.2k
N. Moustaïd United States 16 538 1.6× 187 0.8× 300 1.3× 507 2.2× 182 0.9× 20 1.3k
Yuzuru Ohshiro Japan 13 211 0.6× 100 0.4× 106 0.4× 238 1.0× 97 0.5× 20 784
N. Rassouli United States 6 469 1.4× 79 0.3× 550 2.3× 217 0.9× 140 0.7× 7 973
Patrik Löfgren Sweden 16 528 1.5× 160 0.7× 367 1.5× 193 0.8× 95 0.5× 24 895
David J. Pedersen Australia 12 379 1.1× 154 0.6× 245 1.0× 277 1.2× 50 0.2× 14 794
Stephan Francke United States 12 492 1.4× 204 0.8× 380 1.6× 387 1.7× 378 1.8× 20 1.3k
Melissa K. Standridge United States 8 311 0.9× 84 0.3× 193 0.8× 188 0.8× 86 0.4× 8 679

Countries citing papers authored by Gregory O. Clark

Since Specialization
Citations

This map shows the geographic impact of Gregory O. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory O. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory O. Clark more than expected).

Fields of papers citing papers by Gregory O. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory O. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory O. Clark. The network helps show where Gregory O. Clark may publish in the future.

Co-authorship network of co-authors of Gregory O. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory O. Clark. A scholar is included among the top collaborators of Gregory O. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory O. Clark. Gregory O. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Clark, Gregory O., et al.. (2017). Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study. Diabetes Care. 40(5). 694–697. 33 indexed citations
2.
Harrison, Lindsay, et al.. (2013). Type 1 Diabetes Treatment beyond Insulin: Role of GLP-1 Analogs. Journal of Investigative Medicine. 61(1). 40–44. 39 indexed citations
3.
Wang, May-Yun, Xinxin Yu, Young Lee, et al.. (2012). Iatrogenic hyperinsulinemia in type 1 diabetes: Its effect on atherogenic risk markers. Journal of Diabetes and its Complications. 27(1). 70–74. 29 indexed citations
4.
Wang, May-Yun, Lijun Chen, Gregory O. Clark, et al.. (2010). Leptin therapy in insulin-deficient type I diabetes. Proceedings of the National Academy of Sciences. 107(11). 4813–4819. 262 indexed citations
5.
Unger, Roger H., Gregory O. Clark, Philipp E. Scherer, & Lelio Orci. (2009). Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1801(3). 209–214. 476 indexed citations
6.
Clark, Gregory O., et al.. (2007). Glucose responsive insulin production from human embryonic germ (EG) cell derivatives. Biochemical and Biophysical Research Communications. 356(3). 587–593. 7 indexed citations
7.
Shamblott, Michael J. & Gregory O. Clark. (2004). Cell therapies for type 1 diabetes mellitus. Expert Opinion on Biological Therapy. 4(3). 269–277. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026